RNCOS Releases Report on Booming Clinical Trials Market in India

Released on: February 5, 2008, 3:39 am

Press Release Author: Shushmul Maheshwari

Industry: Biotech

Press Release Summary: The market research company RNCOS has recently released a
report “Booming Clinical Trials Market in India” to give first-hand
information on the emerging Indian clinical trials market.

Press Release Body: The market research company RNCOS has recently released a report
“Booming Clinical Trials Market in India” to give first-hand information
on the emerging Indian clinical trials market. It investigates the key competitive
advantages/disadvantages India has in the field of conducting clinical trials and
does a thorough study of the key factors impacting the country’s clinical
trials, such as patient pool, patient recruitment, cost, time, government
regulations, intellectual property, human resources, infrastructure and ethical
issues.

Market Analysis

India, with its huge patient base, low cost advantage, completion of clinical trials
on time, improving infrastructure, and with a strong government support is
witnessing a double digit growth in its clinical trials market. All major
pharmaceutical companies and Clinical Research Organizations (CROs) have already
started conducting their clinical trials in India, and with improving
infrastructure, industry friendly regulations and trained workforce, the growth is
only likely to increase in future.

However, to achieve its goal of becoming a global hub of clinical trials, the
country will have to overcome challenges like unethical trials, delay in trial
approval, inappropriate protection of clinical data, and lack of Good Clinical
Practice (GCP) certified sites and investigators.

Key Issues and Facts Analyzed

- Evaluation of past, current and future market trends.
- Discussion about the factors driving the clinical research market.
- An analysis of the opportunities created by the market.
- A review on the government regulations on the market.
- An analysis of the major challenges faced by the market.

Key Players Analyzed

This section provides the overview, key facts financial information of prominent
players in the Indian clinical trials market like Quintiles, Ranbaxy, Dr
Reddy’s Laboratories, Roche, Pfizer etc.

Research Methodology Used

Information Sources

Information has been sourced from books, newspapers, trade journals, and white
papers, industry portals, government agencies, trade associations, monitoring
industry news and developments, and through access to more than 3000 paid databases.

Analysis Methods

The analysis methods include ratio analysis, historical trend analysis, linear
regression analysis using software tools, judgmental forecasting, and cause and
effect analysis.
For more information visit: http://www.rncos.com/Report/IM564.htm
Current Industry News: http://www.rncos.com/Blog/


Web Site: http://www.rncos.com/

Contact Details: 29, 1st Floor, Patparganj Industrial Area, Delhi 92
91-11-4214-1229
91-11-4214-1228
info@rncos.com

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •